Prognostic impact of DNA-image-cytometry in neuroendocrine (carcinoid) tumours

Comment

I Petersen. Cell Oncol. 2006.

. 2006;28(3):117-8; author reply 119-20.

doi: 10.1155/2006/754730.

No abstract available

Comment on

Prognostic impact of DNA-image-cytometry in neuroendocrine (carcinoid) tumours.
Raatz H, Böcking A, Hauptmann S. Raatz H, et al. Cell Oncol. 2004;26(1-2):81-8. doi: 10.1155/2004/195478. Cell Oncol. 2004. PMID: 15371660 Free PMC article.

Prognostic impact of DNA-image-cytometry in neuroendocrine (carcinoid) tumours.
Raatz H, Böcking A, Hauptmann S. Raatz H, et al. Cell Oncol. 2004;26(1-2):81-8. doi: 10.1155/2004/195478. Cell Oncol. 2004. PMID: 15371660 Free PMC article.
Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival.
Oberg K. Oberg K. Ann N Y Acad Sci. 1994 Sep 15;733:46-55. doi: 10.1111/j.1749-6632.1994.tb17255.x. Ann N Y Acad Sci. 1994. PMID: 7978895 Review. No abstract available.
[Morphology, DNA cytophotometry and prognosis in gastrointestinal neuroendocrine tumours (carcinoids). A clinico-pathological study of 95 patients].
Padberg BC, Städtler C, Jochum W, Schröder S. Padberg BC, et al. Pathologe. 2000 Jan;21(1):73-81. doi: 10.1007/s002920050008. Pathologe. 2000. PMID: 10663671 German.
Neuroendocrine tumours: clinical presentation and management of localized disease.
Kulke MH. Kulke MH. Cancer Treat Rev. 2003 Oct;29(5):363-70. doi: 10.1016/s0305-7372(03)00072-0. Cancer Treat Rev. 2003. PMID: 12972355 Review.
[Neuroendocrine tumors of the gastrointestinal tract].
Klöppel G. Klöppel G. Pathologe. 2003 Jul;24(4):287-96. doi: 10.1007/s00292-003-0636-7. Epub 2003 May 29. Pathologe. 2003. PMID: 14513276 Review. German.